Regenerative Effects of α-Mangostin-Loaded ZnO Nanoparticles on Wound Healing: In Vitro and Zebrafish In Vivo Insights
DOI:
https://doi.org/10.65795/25rb5v40Keywords:
a-mangostin, human, health, disease, medicineAbstract
α-Mangostin, a key bioactive compound derived from the peel of Garcinia mangostana, is known for its wound-healing potential. This study aims to evaluate the synergistic effects of α-Mangostin-derived zinc oxide nanoparticles (α-Mangostin–ZnO NPs) on wound healing, with emphasis on antimicrobial, anti-inflammatory, antioxidant, and molecular mechanisms. α-Mangostin–ZnO nanoparticles were assessed using in vitro antimicrobial assays against wound-associated pathogens (Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Vibrio vulnificus). Anti-inflammatory activity was evaluated by protein denaturation inhibition using ibuprofen as a reference, while antioxidant potential was assessed using the DPPH free radical scavenging assay. In silico molecular docking was performed against key target proteins (7S53, 4NG2, 20MF, and 5TV2). In vivo wound-healing efficacy was examined using a zebrafish wound model, along with RT-PCR analysis of inflammatory gene expression. α-Mangostin–ZnO NPs exhibited enhanced antimicrobial activity compared to individual components. Significant inhibition of protein denaturation and strong DPPH radical scavenging activity indicated potent anti-inflammatory and antioxidant effects. Molecular docking revealed strong binding affinities with antimicrobial, oxidative stress, inflammatory, and wound-healing proteins. RT-PCR analysis showed marked downregulation of pro-inflammatory markers (mmp13, TNF-α, and IL-1β). Zebrafish studies demonstrated accelerated wound closure and improved tissue regeneration. The findings demonstrate that α-Mangostin–ZnO NPs act as a multifunctional wound-healing agent by integrating antimicrobial, antioxidant, and anti-inflammatory actions, supported by molecular targeting. This nanoplatform shows strong potential for future wound-healing applications.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Taniya Mary Martin, Johann Ajith Prem, Meenakshi Sundaram Kishore Kumar (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.
How to Cite
Accepted 19-06-2026
Published 09-07-2026


